456 related articles for article (PubMed ID: 35982454)
21. ACE-2, TMPRSS2, and Neuropilin-1 Receptor Expression on Human Brain Astrocytes and Pericytes and SARS-CoV-2 Infection Kinetics.
Malik JR; Acharya A; Avedissian SN; Byrareddy SN; Fletcher CV; Podany AT; Dyavar SR
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37239978
[TBL] [Abstract][Full Text] [Related]
22. Neurotropism of SARS-CoV-2 and neurological diseases of the central nervous system in COVID-19 patients.
Veleri S
Exp Brain Res; 2022 Jan; 240(1):9-25. PubMed ID: 34694467
[TBL] [Abstract][Full Text] [Related]
23. In Vivo Targeting of the Neurovascular Unit: Challenges and Advancements.
Naranjo O; Osborne O; Torices S; Toborek M
Cell Mol Neurobiol; 2022 Oct; 42(7):2131-2146. PubMed ID: 34086179
[TBL] [Abstract][Full Text] [Related]
24. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
[TBL] [Abstract][Full Text] [Related]
25. SARS-CoV-2 induces blood-brain barrier and choroid plexus barrier impairments and vascular inflammation in mice.
Qiao H; Deng X; Qiu L; Qu Y; Chiu Y; Chen F; Xia S; Muenzel C; Ge T; Zhang Z; Song P; Bonnin A; Zhao Z; Yuan W
J Med Virol; 2024 May; 96(5):e29671. PubMed ID: 38747003
[TBL] [Abstract][Full Text] [Related]
26. SARS-CoV-2 journey to the brain with a focus on potential role of docosahexaenoic acid bioactive lipid mediators.
Hachem M
Biochimie; 2021 May; 184():95-103. PubMed ID: 33639198
[TBL] [Abstract][Full Text] [Related]
27. Role of the SARS-CoV-2 Virus in Brain Cells.
Azargoonjahromi A
Viral Immunol; 2024 Mar; 37(2):61-78. PubMed ID: 38315740
[TBL] [Abstract][Full Text] [Related]
28. COVID-19 and cognitive impairment: neuroinvasive and blood‒brain barrier dysfunction.
Chen Y; Yang W; Chen F; Cui L
J Neuroinflammation; 2022 Sep; 19(1):222. PubMed ID: 36071466
[TBL] [Abstract][Full Text] [Related]
29. COVID-19-Associated Neurological Disorders: The Potential Route of CNS Invasion and Blood-Brain Relevance.
Achar A; Ghosh C
Cells; 2020 Oct; 9(11):. PubMed ID: 33120941
[TBL] [Abstract][Full Text] [Related]
30. COVID-19 and neurodegeneration: The mitochondrial connection.
Denaro CA; Haloush YI; Hsiao SY; Orgera JJ; Osorio T; Riggs LM; Sassaman JW; Williams SA; Monte Carlo AR; Da Costa RT; Grigoriev A; Solesio ME
Aging Cell; 2022 Nov; 21(11):e13727. PubMed ID: 36219531
[TBL] [Abstract][Full Text] [Related]
31. Evidence of Coronavirus (CoV) Pathogenesis and Emerging Pathogen SARS-CoV-2 in the Nervous System: A Review on Neurological Impairments and Manifestations.
Jha NK; Ojha S; Jha SK; Dureja H; Singh SK; Shukla SD; Chellappan DK; Gupta G; Bhardwaj S; Kumar N; Jeyaraman M; Jain R; Muthu S; Kar R; Kumar D; Goswami VK; Ruokolainen J; Kesari KK; Singh SK; Dua K
J Mol Neurosci; 2021 Nov; 71(11):2192-2209. PubMed ID: 33464535
[TBL] [Abstract][Full Text] [Related]
32. Neurological Complications Associated with the Blood-Brain Barrier Damage Induced by the Inflammatory Response During SARS-CoV-2 Infection.
Alquisiras-Burgos I; Peralta-Arrieta I; Alonso-Palomares LA; Zacapala-Gómez AE; Salmerón-Bárcenas EG; Aguilera P
Mol Neurobiol; 2021 Feb; 58(2):520-535. PubMed ID: 32978729
[TBL] [Abstract][Full Text] [Related]
33. Severe acute respiratory syndrome coronavirus 2 infection reaches the human nervous system: How?
Uversky VN; Elrashdy F; Aljadawi A; Ali SM; Khan RH; Redwan EM
J Neurosci Res; 2021 Mar; 99(3):750-777. PubMed ID: 33217763
[TBL] [Abstract][Full Text] [Related]
34. Shared Inflammatory Pathology of Stroke and COVID-19.
Sánchez KE; Rosenberg GA
Int J Mol Sci; 2022 May; 23(9):. PubMed ID: 35563537
[TBL] [Abstract][Full Text] [Related]
35. Blood-brain barrier function in response to SARS-CoV-2 and its spike protein.
Suprewicz Ł; Fiedoruk K; Czarnowska A; Sadowski M; Strzelecka A; Galie PA; Janmey PA; Kułakowska A; Bucki R
Neurol Neurochir Pol; 2023; 57(1):14-25. PubMed ID: 36810757
[TBL] [Abstract][Full Text] [Related]
36. Current Perspective of COVID-19 on Neurology: A Mechanistic Insight.
Kumar R; Harilal S; M S; Pappachan LK; P R R; Mathew B
Comb Chem High Throughput Screen; 2022; 25(5):763-767. PubMed ID: 34353250
[TBL] [Abstract][Full Text] [Related]
37. Profiling the neurovascular unit unveils detrimental effects of osteopontin on the blood-brain barrier in acute ischemic stroke.
Spitzer D; Guérit S; Puetz T; Khel MI; Armbrust M; Dunst M; Macas J; Zinke J; Devraj G; Jia X; Croll F; Sommer K; Filipski K; Freiman TM; Looso M; Günther S; Di Tacchio M; Plate KH; Reiss Y; Liebner S; Harter PN; Devraj K
Acta Neuropathol; 2022 Aug; 144(2):305-337. PubMed ID: 35752654
[TBL] [Abstract][Full Text] [Related]
38. Review of Neurological Manifestations of SARS-CoV-2.
Priyal ; Sehgal V; Kapila S; Taneja R; Mehmi P; Gulati N
Cureus; 2023 Apr; 15(4):e38194. PubMed ID: 37257164
[TBL] [Abstract][Full Text] [Related]
39. Can SARS-CoV-2 infect the central nervous system via the olfactory bulb or the blood-brain barrier?
Burks SM; Rosas-Hernandez H; Alejandro Ramirez-Lee M; Cuevas E; Talpos JC
Brain Behav Immun; 2021 Jul; 95():7-14. PubMed ID: 33412255
[TBL] [Abstract][Full Text] [Related]
40. Spectrum of Neurological Manifestations in Covid-19: A Review.
Garg RK
Neurol India; 2020; 68(3):560-572. PubMed ID: 32643664
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
